Pluri Inc. — Director's Dealing 2013

Jun 27, 2013

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Check this box if no longer subject to Section 16. Form 4 STATEMENT OF CHANGES IN BENEFICIAL

or Form 5 obligations may OWNERSHIP continue. See Instruction 1(b).

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number: 3235-0287 Expires: December 31, 2014 Estimated average burden hours 0.5 per response

1. Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to Issuer 1. Name and Address of Reporting Person[*] PLURISTEM THERAPEUTICS (Check all applicable) MERETZKI HAVA 0001268789 INC [ PSTI ] X Director 10% Owner Officer (give title Other (specify (Last) (First) (Middle) below) below)

(Last) (First) (Middle) below) below) 3. Date of Earliest Transaction (Month/Day/Year) 38 RAUL WALLENBERG ST. 06/27/2013 (Street) 4. If Amendment, Date of Original Filed 6. Individual or Joint/Group Filing (Check (Month/Day/Year) Applicable Line) HAIFA L3 34990 X Form filed by One Reporting Person Form filed by More than One Reporting Person (City) (State) (Zip) Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction 2A. Deemed 3. 4. Securities Acquired (A) 5. Amount of 6. 7. Nature Date Execution Date, if Transaction or Disposed Of (D) (Instr. Securities Ownership of Indirect (Month/Day/Year) any Code (Instr. 3, 4 and 5) Beneficially Form: Direct Beneficial (Month/Day/Year) 8) Owned (D) or Ownership Following Indirect (I) (Instr. 4) (A) Reported (Instr. 4) Code V Amount or Price Transaction(s) (D) (Instr. 3 and 4) Common Stock 06/27/2013[(1)] A 50,000 A $0 265,208 D Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of 2. 3. Transaction 3A. Deemed 4. 5. 6. Date Exercisable and 7. Title and 8. Price 9. Number 10. 11. Nature Derivative Conversion Date Execution Date, if Transaction Number Expiration Date Amount of of of Ownership of Indirect Security or Exercise (Month/Day/Year) any Code (Instr. of (Month/Day/Year) Securities Derivative Derivative Form: Beneficial (Instr. 3) Price of (Month/Day/Year) 8) Derivative Underlying Security Securities Direct (D) Ownership Derivative Securities Derivative (Instr. 5) Beneficially or Indirect (Instr. 4) Security Acquired Security (Instr. Owned (I) (Instr. (A) or 3 and 4) Following 4) Disposed Reported of (D) Transaction (Instr. 3, (s) (Instr. 4) 4 and 5) Amount or Number Date Expiration of Code V (A) (D) Exercisable Date Title Shares

Explanation of Responses:

1. The shares vest as follows: 25% after 6 months from grant and the remaining shares vest in 6 equal installments every 3 months thereafter. Remarks:

s/ Hava Meretzki 06/27/2013 Date

** Signature of Reporting Person

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.